Peter Chu
Fondateur chez Eclipse Bioinnovations, Inc.
Profil
Peter Chu was the founder of Eclipse Therapeutics, Inc. (founded in 2011) where he held the title of Chief Executive Officer in 2011.
Dr. Chu also held former positions as Director at Discover Echo, Inc. and Scientist at Biogen, Inc. Dr. Chu received his undergraduate degree from McGill University, graduate degree from the University of Toronto, and doctorate from the University of California San Diego.
Dr. Chu is also the founder of Eclipse Bioinnovations, Inc.
Postes actifs de Peter Chu
| Sociétés | Poste | Début |
|---|---|---|
Eclipse Bioinnovations, Inc.
 Eclipse Bioinnovations, Inc. Packaged SoftwareTechnology Services Eclipse Bioinnovations, Inc. is a private biotechnology company that develops first-in-class technologies to accelerate the development of RNA genomics discoveries and medicines. The company is based in San Diego, CA. The company offers its end-to-end RNA genomics products as services and kits and also provides custom RNA genomics services for select partners. Laboratory at UC San Diego. Eclipse Bio is an RNA next-generation sequencing (NGS) company founded in 2017 based on technologies and algorithms developed in Dr. The company was founded by Alexander Shishkin, Peter Chu, and Eugene W. Yeo. Peter Chu has been the CEO since incorporation. | Fondateur | - |
Anciens postes connus de Peter Chu
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | - |
Discover Echo, Inc.
 Discover Echo, Inc. Medical SpecialtiesHealth Technology Discover Echo, Inc. manufactures hybrid microscope for laboratories. Its applications include brightfield, phase contrast, and epi-fluorescence. The company was founded by Eugene Cho and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Eclipse Therapeutics, Inc.
 Eclipse Therapeutics, Inc. BiotechnologyHealth Technology Eclipse Therapeutics, Inc. is a private biotechnology company dedicated to the discovery and development of therapeutics that target cancer stem cells and other forms of innovative cancer treatment. Cancer stem cells are a subset of cells within a tumor thought to play a critical role in tumor initiation, metastasis and recurrence. They are also implicated in resistance to current standard of care cancer treatments. Eclipse is leveraging its deep expertise in cancer stem cell biology and therapeutic antibodies to develop novel therapeutics that address unmet needs in cancer patient care. Eliminating cancer stem cells, in conjunction with other therapies that address the tumor bulk, represents a new cancer treatment paradigm that could offer a distinct advantage over existing strategies and a solution for chemo resistance. The company was founded in March 2011 by former Biogen Idec employees, Peter Chu, Christopher Reyes and Jonathan Lim and is headquartered in San Diego, CA. | Fondateur | - |
Formation de Peter Chu
| McGill University | Undergraduate Degree |
| University of Toronto | Graduate Degree |
| University of California San Diego | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Eclipse Therapeutics, Inc.
Eclipse Therapeutics, Inc. BiotechnologyHealth Technology Eclipse Therapeutics, Inc. is a private biotechnology company dedicated to the discovery and development of therapeutics that target cancer stem cells and other forms of innovative cancer treatment. Cancer stem cells are a subset of cells within a tumor thought to play a critical role in tumor initiation, metastasis and recurrence. They are also implicated in resistance to current standard of care cancer treatments. Eclipse is leveraging its deep expertise in cancer stem cell biology and therapeutic antibodies to develop novel therapeutics that address unmet needs in cancer patient care. Eliminating cancer stem cells, in conjunction with other therapies that address the tumor bulk, represents a new cancer treatment paradigm that could offer a distinct advantage over existing strategies and a solution for chemo resistance. The company was founded in March 2011 by former Biogen Idec employees, Peter Chu, Christopher Reyes and Jonathan Lim and is headquartered in San Diego, CA. | Health Technology |
Discover Echo, Inc.
Discover Echo, Inc. Medical SpecialtiesHealth Technology Discover Echo, Inc. manufactures hybrid microscope for laboratories. Its applications include brightfield, phase contrast, and epi-fluorescence. The company was founded by Eugene Cho and is headquartered in San Diego, CA. | Health Technology |
Eclipse Bioinnovations, Inc.
Eclipse Bioinnovations, Inc. Packaged SoftwareTechnology Services Eclipse Bioinnovations, Inc. is a private biotechnology company that develops first-in-class technologies to accelerate the development of RNA genomics discoveries and medicines. The company is based in San Diego, CA. The company offers its end-to-end RNA genomics products as services and kits and also provides custom RNA genomics services for select partners. Laboratory at UC San Diego. Eclipse Bio is an RNA next-generation sequencing (NGS) company founded in 2017 based on technologies and algorithms developed in Dr. The company was founded by Alexander Shishkin, Peter Chu, and Eugene W. Yeo. Peter Chu has been the CEO since incorporation. | Technology Services |
